0001209191-17-037922.txt : 20170605 0001209191-17-037922.hdr.sgml : 20170605 20170605180513 ACCESSION NUMBER: 0001209191-17-037922 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170601 FILED AS OF DATE: 20170605 DATE AS OF CHANGE: 20170605 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA CENTRAL INDEX KEY: 0000875320 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 043039129 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 50 NORTHERN AVENUE CITY: BOSTON STATE: MA ZIP: 02210 BUSINESS PHONE: 6173416393 MAIL ADDRESS: STREET 1: 50 NORTHERN AVENUE CITY: BOSTON STATE: MA ZIP: 02210 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SMITH IAN F CENTRAL INDEX KEY: 0001197032 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19319 FILM NUMBER: 17892473 MAIL ADDRESS: STREET 1: C/O ACORDA THERAPEUTICS, INC. STREET 2: 420 SAW MILL RIVER ROAD CITY: ARDSLEY STATE: NY ZIP: 10502 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2017-06-01 0 0000875320 VERTEX PHARMACEUTICALS INC / MA VRTX 0001197032 SMITH IAN F C/O VERTEX PHARMACEUTICALS INCORPORATED 50 NORTHERN AVENUE BOSTON MA 02210 0 1 0 0 EVP, CFO & COO Common Stock 2017-06-01 4 M 0 37383 45.11 A 163621 D Common Stock 2017-06-01 4 M 0 18124 48.74 A 181745 D Common Stock 2017-06-01 4 M 0 23789 37.86 A 205534 D Common Stock 2017-06-01 4 M 0 9062 51.75 A 214596 D Common Stock 2017-06-01 4 M 0 10195 38.80 A 224791 D Common Stock 2017-06-01 4 S 0 98553 124.00 D 126238 D Common Stock 5306 I 401(k) Stock Option (Right to Buy) 45.11 2017-06-01 4 M 0 37383 0.00 D 2023-02-04 Common Stock 37383 0 D Stock Option (Right to Buy) 48.74 2017-06-01 4 M 0 18124 0.00 D 2022-07-24 Common Stock 18124 0 D Stock Option (Right to Buy) 37.86 2017-06-01 4 M 0 23789 0.00 D 2022-02-01 Common Stock 23789 0 D Stock Option (Right to Buy) 51.75 2017-06-01 4 M 0 9062 0.00 D 2021-07-12 Common Stock 9062 0 D Stock Option (Right to Buy) 38.80 2017-06-01 4 M 0 10195 0.00 D 2021-02-02 Common Stock 10195 0 D Transaction made pursuant to Mr. Smith's company approved trading plan under Rule 10b5-1. Fully vested. Omar White, Attorney-In-Fact 2017-06-05